DK
Dinesh Kundu
About Dinesh Kundu
Data last updated:
Dinesh Kundu is a Partner at Rohtak Nuclear Medcare Llp (since 2024) and Director at East Ocyon Bio Private Limited (since 2022). The companies operate in Healthcare, Pharma and Life Sciences. The 2 current companies with reported revenue have a combined latest revenue of ₹6.67 Cr; the largest is Rohtak Nuclear Medcare Llp at ₹6.35 Cr (FY 2025). Earlier, Dinesh Kundu was a Director at Qbd Biosciences Private Limited (2021–2023) and Director at Prozo Integrated Logistics Private Limited (2015–2016) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Partner | 06 Sep 2024 | 2017 | ₹6.35 Cr (FY 2025) | Active | |
| Director | 14 Mar 2022 | 2022 | ₹32.3 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Sep 2021 | 2017 | ₹40.23 Cr (FY 2023) | Active | |
| Director | 18 Sep 2015 | 2014 | ₹177 Cr (FY 2025) | Active | |
| Director | 07 Oct 2021 | 2021 | ₹14.46 Cr (FY 2024) | Active | |
| Partner | 14 Feb 2020 | 2020 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Dinesh Kundu
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manju | 09661488 | Rohtak Nuclear Medcare Llp | Designated Partner |
| Parveen Kundu | 07944292 | Rohtak Nuclear Medcare Llp | Designated Partner |
| Sajni Devi | 09661739 | Rohtak Nuclear Medcare Llp | Designated Partner |
| Narinder Kumar Mehra | 09535720 | East Ocyon Bio Private Limited | Director |
| Renu | 07711725 | East Ocyon Bio Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dinesh Kundu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dinesh Kundu
Dinesh Kundu currently holds 2 directorships: Rohtak Nuclear Medcare Llp (Partner, since 06 Sep 2024, revenue ₹6.35 Cr (FY 2025)); East Ocyon Bio Private Limited (Director, since 14 Mar 2022, revenue ₹32.3 Lakh (FY 2025)).
Dinesh Kundu was first appointed on 18 Sep 2015 as Director at Prozo Integrated Logistics Private Limited. The most recent appointment on record is 06 Sep 2024 at Rohtak Nuclear Medcare Llp.
The 2 current companies of Dinesh Kundu that report revenue have a combined latest revenue of ₹6.67 Cr: Rohtak Nuclear Medcare Llp ₹6.35 Cr (FY 2025); East Ocyon Bio Private Limited ₹32.3 Lakh (FY 2025).
Dinesh Kundu held 4 earlier board appointments: Qbd Biosciences Private Limited (Director, 02 Sep 2021 to 31 Mar 2023); Prozo Integrated Logistics Private Limited (Director, 18 Sep 2015 to 09 May 2016); Nuclear Medsystems India Private Limited (Director, 07 Oct 2021 to 01 Sep 2022); Xypler Genetech Llp (Partner, from 14 Feb 2020).
The current boards of Dinesh Kundu's companies include Manju (Rohtak Nuclear Medcare Llp), Parveen Kundu (Rohtak Nuclear Medcare Llp), Sajni Devi (Rohtak Nuclear Medcare Llp), Narinder Kumar Mehra (East Ocyon Bio Private Limited), Renu (East Ocyon Bio Private Limited).